ThermaFreeze Launches Bio-Remediation and Treatment of Highly Carcinogenic of Chromium VI
MOBILE, Ala., May 1, 2001 (BUSINESS WIRE) -- ThermaFreeze, Inc., (TM) (OTC: BB chart, msgs THFZ chart, msgs) is pleased to announce that its Glasgow based subsidiary has made significant progress in it's Chromium VI Bio-Reduction Project. ERS was recently awarded a contract to develop a biological solution for the City of Glasgow, Scotland's sites contaminated with hexavalent chromium.
Andrew Mackenzie, Managing Director of ERS, said today "Laboratory testing was now complete and preparations for the field scale demonstration were being made. It is anticipated that a field demonstration will be completed during the next 4 months. The conversion of highly carcinogenic and toxic Chromium VI to inert Chromium III by biological reduction would effectively treat soils in-situ reducing the costs associated with excavation and removal as well as eliminating the associated environmental and health risks."
"This dangerous chemical has become a complex problem in many places of the world because the only proven effective treatments require removal of contaminated soils for isolation of the Chromium VI," states Dr. Loven, Chairman of Thermafreeze. "As it is often found in the soils beneath major industrial or urban areas, the problems of solid removal can be insurmountable.
We are extremely pleased to have this opportunity to introduce a new, compelling technology capable of rendering this valuable industry necessary chemical into a harmless by-product while it is still in the soil.
This initiative is representative of the synergies of our roll up strategy and demonstrates our ability to attract leading edge technology into our group for commercial application and exploitation. We anticipate ongoing news and developments in advanced bio-remediation and treatments of various strategic environmental pollutants in the following weeks."
ThermaFreeze(TM) Inc. is a consolidator and operator of environmentally related businesses. Acquisitions and growth focus on energy, air, and water sectors. ThermaFreeze(TM) Inc. expects to sustain growth through its aggressive roll up strategy and internal synergies.
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third party suppliers, intellectual property rights and the other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission Fair Disclosure Regulation, effective, October 2000.
Contact:
ThermaFreeze, Inc.
Dr. Galen Dean Loven, 509/921-9150
thfzinc.com
gdl@morals.net |
